China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Vice-chairman of CPPCC Jiangxi Provincial Committee placed under investigation
- Five trapped in flooding accident at Heilongjiang coal mine
- Long March 5 rocket deploys tech demo satellite into space
- China launches communication technology test satellite
- Spokesperson warns against aggression toward mainland fisherman
- Lhasa wetland reserve recognized as world's highest altitude wetland
